by Asgeir S. Jakola, Sasha Gulati, Clemens Weber, Geirmund Unsgård, Ole Solheim
Studies indicate that acquired deficits negatively affect patients' self-reported health related quality of life (HRQOL) and survival, but the impact of HRQOL deterioration after surgery on survival has not been explored. Objective
Assess if change in HRQOL after surgery is a predictor for survival in patients with glioblastoma. Methods
Sixty-one patients with glioblastoma were included. The majority of patients (n?=?56, 91.8%) were operated using a neuronavigation system which utilizes 3D preoperative MRI and updated intraoperative 3D ultrasound volumes to guide resection. HRQOL was assessed using EuroQol 5D (EQ-5D), a generic instrument. HRQOL data were collected 1–3 days preoperatively and after 6 weeks. The mean change in EQ-5D index was -0.05 (95% CI -0.15–0.05) 6 weeks after surgery (p?=?0.285). There were 30 patients (49.2%) reporting deterioration 6 weeks after surgery. In a Cox multivariate survival analysis we evaluated deterioration in HRQOL after surgery together with established risk factors (age, preoperative condition, radiotherapy, temozolomide and extent of resection). Results
There were significant independent associations between survival and use of temozolomide (HR 0.30, p?=?0.019), radiotherapy (HR 0.26, p?=?0.030), and deterioration in HRQOL after surgery (HR 2.02, p?=?0.045). Inclusion of surgically acquired deficits in the model did not alter the conclusion. Conclusion
Early deterioration in HRQOL after surgery is independently and markedly associated with impaired survival in patients with glioblastoma. Deterioration in patient reported HRQOL after surgery is a meaningful outcome in surgical neuro-oncology, as the measure reflects both the burden of symptoms and treatment hazards and is linked to overall survival.